A detailed history of Mcdaniel Terry & CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Mcdaniel Terry & CO holds 14,905 shares of ABBV stock, worth $2.54 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
14,905
Previous 17,612 15.37%
Holding current value
$2.54 Million
Previous $2.73 Million 0.55%
% of portfolio
0.24%
Previous 0.26%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$159.82 - $182.1 $432,632 - $492,944
-2,707 Reduced 15.37%
14,905 $2.71 Million
Q4 2023

Jan 24, 2024

SELL
$137.6 - $154.97 $51,049 - $57,493
-371 Reduced 2.06%
17,612 $2.73 Million
Q3 2023

Oct 23, 2023

BUY
$133.59 - $154.65 $427,087 - $494,416
3,197 Added 21.62%
17,983 $2.68 Million
Q2 2023

Jul 21, 2023

BUY
$132.51 - $164.9 $65,459 - $81,460
494 Added 3.46%
14,786 $1.99 Million
Q1 2023

May 05, 2023

BUY
$144.61 - $166.54 $7,085 - $8,160
49 Added 0.34%
14,292 $2.28 Million
Q4 2022

Jan 23, 2023

SELL
$138.31 - $165.87 $87,135 - $104,498
-630 Reduced 4.24%
14,243 $2.3 Million
Q3 2022

Oct 06, 2022

SELL
$134.21 - $153.93 $7,381 - $8,466
-55 Reduced 0.37%
14,873 $2 Million
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $286,524 - $364,266
-2,082 Reduced 12.24%
14,928 $2.29 Million
Q1 2022

Apr 27, 2022

SELL
$131.98 - $163.75 $2 Million - $2.49 Million
-15,188 Closed
0 $0
Q4 2021

Jan 20, 2022

BUY
$107.43 - $135.93 $5,264 - $6,660
49 Added 0.32%
15,188 $2.06 Million
Q3 2021

Dec 06, 2021

BUY
$106.4 - $120.78 $6,490 - $7,367
61 Added 0.4%
15,139 $1.63 Million
Q2 2021

Aug 11, 2021

SELL
$105.21 - $117.21 $2,735 - $3,047
-26 Reduced 0.17%
15,078 $1.7 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $6,035 - $6,644
59 Added 0.39%
15,104 $1.64 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $1,931 - $2,608
24 Added 0.16%
15,045 $1.61 Million
Q3 2020

Nov 09, 2020

BUY
$85.91 - $100.83 $2,147 - $2,520
25 Added 0.17%
15,021 $1.32 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $26,193 - $35,050
357 Added 2.44%
14,996 $1.47 Million
Q1 2020

May 08, 2020

SELL
$64.5 - $97.79 $45,472 - $68,941
-705 Reduced 4.59%
14,639 $1.12 Million
Q4 2019

Feb 03, 2020

SELL
$72.13 - $90.25 $12,694 - $15,884
-176 Reduced 1.13%
15,344 $1.36 Million
Q3 2019

Nov 07, 2019

BUY
$62.98 - $75.72 $30,986 - $37,254
492 Added 3.27%
15,520 $1.18 Million
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $306,621 - $391,934
-4,667 Reduced 23.7%
15,028 $1.09 Million
Q1 2019

May 09, 2019

BUY
$77.14 - $90.79 $58,009 - $68,274
752 Added 3.97%
19,695 $0
Q4 2018

Feb 07, 2019

BUY
$77.85 - $96.01 $778 - $960
10 Added 0.05%
18,943 $1.75 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $32,718 - $36,373
368 Added 1.98%
18,933 $1.79 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $1,526 - $1,805
17 Added 0.09%
18,565 $1.72 Million
Q1 2018

May 11, 2018

BUY
$92.01 - $123.21 $1,012 - $1,355
11 Added 0.06%
18,548 $1.76 Million
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $10,120 - $11,097
-113 Reduced 0.61%
18,537 $1.79 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $1,117 - $1,427
16 Added 0.09%
18,650 $1.66 Million
Q2 2017

Aug 10, 2017

BUY
N/A
18,634
18,634 $1.35 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mcdaniel Terry & CO Portfolio

Follow Mcdaniel Terry & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdaniel Terry & CO, based on Form 13F filings with the SEC.

News

Stay updated on Mcdaniel Terry & CO with notifications on news.